Models for change in clinical microbiology

Clinical Microbiology and Infection

Volumn 6, Issue 8, 2000, Pages 445-448

  Van Eldere, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DNA; RNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL LABORATORY; CLINICAL PRACTICE; COMPUTER ANALYSIS; COMPUTER SYSTEM; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIAGNOSTIC PROCEDURE; DNA EXTRACTION; GENETIC ANALYSIS; HOSPITAL PATIENT; HUMAN; INCUBATION TIME; INFECTION; INFORMATION PROCESSING; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MODEL; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RNA EXTRACTION; SPECIES IDENTIFICATION;

BACTERIA (MICROORGANISMS);

EID: 0034256906     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00118.x     Document Type: Article

References (16)

1. PSG Hospital Anti-Infective database 1995. I. MS. #AG, 6330 Charn, Switzerland.
2. Matsen JM. Means to facilitate physician acceptance and use of rapid test results. Diagn Microbiol Infect Dis 1985; 3: 73S-8S.
3. Koontz FP. Rapid results reporting and the physician's use of MIC's. Clin Microbiol Newsletter 1991; 13: 172-4.
4. Gordon M, Trenholme GM, Raymond L et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 1989; 27: 1342-5.
5. Koontz FP. Clinical utilization of rapid antibiotic susceptibility data: a prospective study. Adv Exp Med Biol 1994; 349: 27-34.
6. Robinson A, Marcon M, Mortensen JE et al. Controversies affecting the future practice of clinical microbiology. J Clin Microbiol 1999; 37: 883-9.
7. Doern GV, Scott DR, Rashad AL. Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 1982; 21: 1023-4.
8. Vincent P, Izard D, Lebrun Th et al. Intérêt clinique des résultats rapides de bactériologie au cours de l'infection nosocomiale. Presse Med 1985; 14: 1697-700.
9. Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994; 32: 1757-62.
10. Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999; 37: 1415-18.
11. True BL, Carter BL, Driscoll CE, House JD. Effect of a rapid diagnostic method on prescribing patterns and ordering of throat cultures for streptococcal pharyngitis. J Family Pract 1986; 23: 215-19.
12. Staneck JL. Screening tests and 'rapid' identification. Is anybody out there listening? Diagn Microbiol Infect Dis 1985; 3: 51S-7S.
13. Relman DA, Falkow S. A molecular perspective of microbial pathogenicity. In: Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th edn. New York: Elsevier Science, 1995: 19-29.
14. Covacci A, Falkow S, Berg DE, Rappuoli R. Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol 1997; 5: 205-8.
15. Troesch A, Nguyen H, Miyada CG et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 1999; 37: 49-55.
16. Gingeras TR, Ghandour G, Wang E et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998; 8: 435-48.